Fundraising Fox
/People
Sign in

Eric Shiozaki, PhD

Investor

Partner at Revelation Partners · Board director at Auron Therapeutics

San Francisco, California, United States

Writes $5M – $50M checks

Find your path to Eric

255 people in our graph share verified history with Eric — schools, employers, funds. One of them is your warm intro.

Linda GreubunlockedEric: together at VitaPath Genetics (2009)
×4Eric: together at Burrill & Company
×5Eric: together at DCVC Bio
×2Eric: together at Apposite Capital

About

Eric Shiozaki’s background as a structural biologist (PhD in Molecular Biology, Princeton) combined with cross-stage investing in early biotech, late private and secondaries gives him panoramic biopharma and device insight.

Contact· self-published, not guessed

Invests in

BiotechHealthtechMedical Devices

Board director at Auron Therapeutics

Intro paths

→

In turn, Eric can intro founders to Auron Therapeutics's investors below.

Auron Therapeutics's investors · 4

Apollo Health VenturesBerlin · since 2022DCVC (Data Collective)Palo Alto · $5M – $25M checksDCVC BioPalo Alto · since 2022Polaris PartnersBoston · $500K – $5M checks · since 2025

Co-founders at Auron Therapeutics

KY
Katharine YenExecutive Officer, Director
KYKate Yen
Kate YenFounder

Experience

  1. Revelation PartnersPartnercurrent2025 — presentSan Francisco Bay Area
  2. Revelation PartnersVenture Partner2024 — 2025San Francisco Bay Area
  3. DCVC BioPartner2021 — 2024San Francisco Bay Area
  4. Novo HoldingsPartner - Novo Ventures2018 — 2021San Francisco Bay Area
  5. Novo HoldingsPrincipal - Novo Ventures2014 — 2017San Francisco Bay Area
  6. Apposite CapitalDirector2011 — 2014San Francisco Bay Area
  7. Apposite CapitalAssociate Director2009 — 2011San Francisco Bay Area
  8. VitaPath GeneticsDirector of Corporate Development & Strategy2009San Francisco Bay Area
  9. Burrill & CompanyAssociate2007 — 2008San Francisco Bay Area
  10. Burrill & CompanyIntern2007San Francisco Bay Area
  11. University of California, Los AngelesTechnology Transfer Associate2006 — 2007Los Angeles
  12. University of California, Los AngelesLeukemia & Lymphoma Society Postdoctoral Fellow2004 — 2007Los Angeles
  13. Princeton UniversityPostdoctoral Researcher2003 — 2004Princeton, New Jersey, United States

Skills & more

Biotechnology8Venture Capital27Technology Transfer9Medical Devices6Investments8Start-ups20Management2Entrepreneurship10Due Diligence10Corporate Development9Portfolio Management2Corporate Finance2
+8 moreStrategyMergers & AcquisitionsFinancePrivate EquityProtein ChemistryLifesciencesGeneticsPharmaceutical Industry

From Eric's professional profile.

Investments

Investor

Ascend Gene & Cell TherapiesAuron TherapeuticsRadionetics OncologyVitalConnect

Per curated public sources.

What founders say

No founder feedback on Eric Shiozaki, PhD yet.

Leave your own feedback

Colleagues at Revelation Partners

Chris Bayliss
Vice President at Revelation Partners
Colleen Hochberger
Manager, Marketing & Operations at Revelation Partners
David A. Smolen
Executive Officer at REVELATION
Doug Fisher
Partner, MD at Revelation Partners
Doug Fisher, MD
Partner at Revelation Partners
Fred Lee
Partner at Revelation Partners
Garrett Brown
Senior Associate at Revelation Partners
Jonathan Au
Partner at Revelation Partners

Network8

Alan CohenScout
General Partner at DCVC (Data Collective)
Ali TamasebScout
General Partner at DCVC (Data Collective)
Chris BoshuizenScout
Partner at DCVC (Data Collective)
James HardimanScout
General Partner at DCVC (Data Collective)
Jason PontinScout
General Partner at DCVC (Data Collective)
Anna Fokina
Investment Director DCVC Bio at DCVC (Data Collective)
Daniel Coley
Associate at Cofounders Capital
Irfan Ahmad
Investor at DCVC (Data Collective)

Investors connected to Eric in public investor directories — a warm-intro map.

Frequently asked questions

Who is Eric Shiozaki, PhD?
Eric Shiozaki’s background as a structural biologist (PhD in Molecular Biology, Princeton) combined with cross-stage investing in early biotech, late private and secondaries gives him panoramic biopharma and device insight.
Where does Eric Shiozaki, PhD work?
Eric Shiozaki, PhD is Partner at Revelation Partners and Board director at Auron Therapeutics.
What does Eric Shiozaki, PhD invest in?
Eric Shiozaki, PhD invests in Biotech, Healthtech, Medical Devices.
What check size does Eric Shiozaki, PhD write?
Eric Shiozaki, PhD typically writes checks of $5M – $50M.
What companies has Eric Shiozaki, PhD invested in?
Investments tracked here include Ascend Gene & Cell Therapies, Auron Therapeutics, Radionetics Oncology, VitalConnect.
Where did Eric Shiozaki, PhD go to school?
Eric Shiozaki, PhD studied at Princeton University (Ph.D., Molecular Biology); The Johns Hopkins University (BA, Biophysics).

Same school

Shared employers